The Hindu 2014.04.22 15:40
PTI GlaxoSmithKline Consumer Healthcare on Tuesday said the multi-billion
dollar global deal between parent GlaxoSmithKline Plc. and Swiss drug major
Novartis won't affect its business in India.
The two companies agreed to form a joint venture by combining Novartis'
over-the-counter division with GSK's consumer business to create a business
with $10 billion in annual sales.
VACCINE, ONCOLOGY, DEAL, ELI, MILESTONE, DIVESTITURE, Jimenez, Heilprin, USA, Швейцария
- GSK-Novartis global deal not to impact India business: GSKCH : The Hindu 15:40
- Novartis, GSK, Lilly sign multibillion-dollar deals to trade business units : The Globe and Mail 14:58
- Novartis, GSK, Lilly sign deals to swap business units : Canadian Television 13:34
- Novartis, GSK, Lilly in multibillion-dollar deals : The State 11:56
- GSK In lb8.5bn Deal With Swiss Rival Novartis : Sky News 11:51
- Novartis, GSK, Lilly in multibillion-dollar deals : SFGate.com 11:51
- Novartis, GSK, Lilly in multibillion-dollar deals : Salon.com 11:50
- Novartis, GSK, Lilly in Multibillion-Dollar Deals : ABC news.com 11:28
- GSK In ё8.5bn Deal With Swiss Rival Novartis : Orange News 10:07